Suppression of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in mice by transduced Tat-Annexin protein
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
We examined that the protective effects of ANX1 on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in animal models using a Tat-ANX1 protein. Topical application of the Tat-ANX1 protein markedly inhibited TPAinduced ear edema and expression levels of cyclooxygenase-2(COX-2) as well as pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α). Also, application of Tat-ANX1 protein significantly inhibited nuclear translocation of nuclear factor-kappa B (NF-κB) and phosphorylation of p38 and extracellular signalregulated kinase (ERK) mitogen-activated protein kinase (MAPK) in TPA-treated mice ears. The results indicate that Tat-ANX1 protein inhibits the inflammatory response by blocking NF-κB and MAPK activation in TPA-induced mice ears. Therefore, the Tat-ANX1 protein may be useful as a therapeutic agent against inflammatory skin diseases. [BMB Reports 2012; 45(6): 354-359]
Abstract
We examined that the protective effects of ANX1 on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in animal models using a Tat-ANX1 protein. Topical application of the Tat-ANX1 protein markedly inhibited TPAinduced ear edema and expression levels of cyclooxygenase-2(COX-2) as well as pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α). Also, application of Tat-ANX1 protein significantly inhibited nuclear translocation of nuclear factor-kappa B (NF-κB) and phosphorylation of p38 and extracellular signalregulated kinase (ERK) mitogen-activated protein kinase (MAPK) in TPA-treated mice ears. The results indicate that Tat-ANX1 protein inhibits the inflammatory response by blocking NF-κB and MAPK activation in TPA-induced mice ears. Therefore, the Tat-ANX1 protein may be useful as a therapeutic agent against inflammatory skin diseases. [BMB Reports 2012; 45(6): 354-359]
참고문헌 (29)
- Bertolini, A., "Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks", Curr. Med. Chem., 9, pp.1033~1043 (2002)
- Firestein, G. S., "Evolving concepts of rheumatoid arthritis", Nature, 423, pp.356~361 (2003)
- Korhonen, R., "Nitric oxide production and signaling in inflammation", Curr. Drug Targets Inflamm. Allergy, 4, pp.471~479 (2005)
- Libby, P., "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2000)
- Cho, H. J., "3,3’-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophage", J. Nutr., 138, pp.17~23 (2008)
- Tilley, S. L., "Mixed message gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes", J. Clin. Invest., 107, pp.191~195 (2001)
- Carey, M. A., "Cyclooxygenase enzymes in allergic inflammation and asthma", Prostaglandins Leukot Essent Fatty Acids, 69, pp.157~162 (2003)
- Lee, E., "Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E-2 production in human lung epithelial cells", CARCINOGENESIS, 27, pp.2308~2315 (2006), OXFORD UNIV PRESS
- Vancheri, C., "The lung as a privileged site for the beneficial actionsof PEG2", Trends Immunol., 25, pp.40~46 (2004)
- Buchanan, M. M., "Toll-like receptor 4 in CNS pathologies", J. Neurochem., 114, pp.13~27 (2010)
- Mararov, S. S., "NF-κB as a therapeutic target in chronic inflammation: recent advances", Mol. Med. Today, 6, pp.441~448 (2000)
- Babbin, B., "Annexin A1 regulates intestinal mucosal injury, inflammation, and repair", J. Immunol., 181, pp.5035~5044 (2008)
- Kamal, A. M., "An overview of the effects of annexin 1 on cells involved in the inflammatory process", Mem. Inst. Oswaldo Cruz Rio de Janeiro, 100(Suppl 1), pp.39~48 (2005)
- Perretti, M., "Annexin A1 and glucocorticoids as effectors of the resolution of inflammation", Nat. Rew. Immunol., 9, pp.62~70 (2009)
- Wadia, J., "Protein transduction technology", Curr. Opin. Biotechnol., 13, pp.52~56 (2002)
- Ahn, E. H., "Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice", Toxicology, 276, pp.192~197 (2010)
- An, J. J., "Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult", FEBS JOURNAL, 275, pp.1296~1308 (2008), BLACKWELL PUBLISHING
- Kim, D. W., "Transduced PEP-1-catalase fusion protein attenuates ischemic neuronal damage", Free Radic. Biol. Med., 47, pp.941~952 (2009)
- Sun Hwa Lee, "Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins", BMB Reports, 43(8), pp.561~566 (2010), 생화학분자생물학회
- Sun Hwa Lee, "Transduced Tat-Annexin protein suppresses inflammationassociated gene expression in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells", BMB Reports, 44(7), pp.484~489 (2011), 생화학분자생물학회
- Stanley, P. L., "Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate", Skin Pharmacol., 4, pp.262~271 (1991)
- DeVry, C. G., "Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model", J. Invest. Dermatol., 125, pp.473~481 (2005)
- Ha, H. Y., "Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 348, pp.450~458 (2006), ACADEMIC PRESS INC ELSEVIER SCIENCE
- Murakawa, M., "Involvement of tumor necrosis factor (TNF)-α inphorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice", Biochem. Pharmacol., 71, pp.1331~1336 (2006)
- Flower, R. J., "Lipocortin and the mechanism of action of the glucocorticoid", Br. J. Pharmacol., 94, pp.987~1015 (1988)
- Chiang, N., "Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligands-specific responses in inflammation", J. Exp. Med., 191, pp.1197~1208 (2000)
- Kieran, N. E., "Modification of the transcriptomic response to renal ischemia", reperfusion injury by lipoxin analog, 2003, pp.64, 480~492
- Gayathri, B., "Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF-α, IL-1β, NO and MAP kinases", Int. Immunopharmacol., 7, pp.473~482 (2007)
- Bradford, M. A., "A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding", Anal Biochem., 72, pp.248~254 (1976)
